+629.1%
MRNA vs VRSN
+85.9%
+543.2%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VRSN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +1.7% | -5.0% | -3.8% |
| 7D | -10.1% | -1.0% | -9.0% | -9.8% |
| 30D | +126.7% | -1.9% | +128.6% | +127.5% |
| 3M | +184.1% | +1.4% | +182.7% | +180.4% |
| 6M | +143.3% | +19.0% | +124.2% | +125.5% |
| YTD | +359.9% | +19.2% | +340.6% | +324.4% |
| 1Y | +454.2% | +1.7% | +452.5% | +441.1% |
| 3Y | +26.0% | +41.4% | -15.5% | +7.0% |
| 5Y | -70.3% | +31.7% | -101.9% | -74.6% |
| All | +629.1% | +85.9% | +543.2% | +375.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VRSN.
Daily Out/Under-Performance
Portfolio return minus VRSN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VRSN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VRSN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling